Cyclops Medtech Profile
Key Indicators
- Authorised Capital ₹ 5.00 Cr
as on 06-07-2024
- Paid Up Capital ₹ 0.16 M
as on 06-07-2024
- Company Age 9 Year, 10 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 7.00 M
as on 06-07-2024
- Revenue 19.40%
(FY 2023)
- Profit -81.17%
(FY 2023)
- Ebitda -101.01%
(FY 2023)
- Net Worth 2.71%
(FY 2023)
- Total Assets 12.43%
(FY 2023)
About Cyclops Medtech
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 5.00 Cr and a paid-up capital of Rs 0.16 M.
The company currently has active open charges totaling ₹7.00 M.
Chandanmal Bothra, Dorasala Srinivas, Ravi Nayar, and One other member serve as directors at the Company.
- CIN/LLPIN
U74900KA2015PTC078575
- Company No.
078575
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
29 Jan 2015
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Bangalore
Industry
Company Details
- Location
Bangalore, Karnataka, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does Cyclops Medtech Private Limited offer?
Cyclops Medtech Private Limited offers a wide range of products and services, including ENT Surgical Equipment & Supplies, ENT Equipment.
Who are the key members and board of directors at Cyclops Medtech?
Board Members(4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Dorasala Srinivas  | Director | 29-Jan-2015 | Current |
| Ravi Nayar | Director | 29-Jan-2015 | Current |
| Niranjan Subbarao | Director | 29-Jan-2015 | Current |
| Chandanmal Bothra | Nominee Director | 09-Jul-2018 | Current |
Financial Performance and Corporate Structure Insights of Cyclops Medtech.
Cyclops Medtech Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 19.4% increase. The company also saw a substantial fall in profitability, with a 81.17% decrease in profit. The company's net worth moved up by a moderate rise of 2.71%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Cyclops Medtech?
In 2023, Cyclops Medtech had a promoter holding of 82.30% and a public holding of 17.70%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Hdfc Bank Limited Creation Date: 12 Oct 2023 | ₹7.00 M | Open |
How Many Employees Work at Cyclops Medtech?
Cyclops Medtech has a workforce of 25 employees as of Mar 30, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Cyclops Medtech, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Cyclops Medtech's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
